Company profile: Cure Pharmaceutical
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical and bioscience drug formulation and delivery technologies, featuring the CUREfilm thin-film platform for sublingual and buccal delivery. Offerings include CUREfilm Blue (sildenafil for ED), oral thin-film insulin, CU-2025g for weight management, an oral Hepatitis B vaccine, and CUREfilm-based nutraceuticals.
Products and services
- CUREfilm®: A custom-engineered sublingual/buccal drug delivery system enabling rapid absorption directly into the bloodstream and avoiding first-pass metabolism through sublingual and buccal administration
- CUREfilm® Oral Thin Film Insulin: An oral thin film insulin product developed to eliminate painful injections and address issues related to current insulin treatment methods through convenient oral administration
- Oral Hepatitis B Vaccine: An oral-dose vaccine engineered to improve accessibility and compliance by enabling Hepatitis B immunization through ingestion instead of injections
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cure Pharmaceutical
Milestone Scientific
HQ: United States
Website
- Description: Provider of computer-controlled injection technologies for medical and dental care, including the CompuFlo Epidural Instrument with visual/audio feedback to locate the epidural space; the STA Single Tooth Anesthesia system for precise dental delivery; DPS Dynamic Pressure Sensing and automated flow/pressure control for consistent injections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Milestone Scientific company profile →
Credence MedSystems
HQ: United States
Website
- Description: Provider of drug delivery and specialty pharmaceutical solutions focused on safe medication administration, offering syringe systems including the Companion Safety Syringe with end-of-dose cues, passive needlestick safety, reuse prevention and pre-attached needle; Dual Chamber Reconstitution Syringe; Credence Connect for real-time injection monitoring; Micro-Dose Syringe for ocular use; and Multi-Site Syringe.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Credence MedSystems company profile →
Bionaut Labs
HQ: United States
Website
- Description: Provider of microscale robotic technology for precise delivery of therapies to targeted CNS disease areas; a platform for biologics and small molecules; diagnostic fluid and tissue sampling; long-term in vivo sensing and monitoring; localized electrical stimulation or dampening; and minimally invasive hydrocephalus treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bionaut Labs company profile →
Sedana Medical
HQ: Sweden
Website
- Description: Provider of anaesthetic delivery systems and agents, including the AnaConDa (Anaesthetic Conserving Device) for delivering anaesthetic agents during medical procedures; Sedaconda (isoflurane) for sedation with AnaConDa; Sedasource for continuous anaesthetic agent supply; and FlurAbsorb to absorb and manage anaesthetic gases in medical settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sedana Medical company profile →
H&T Presspart
HQ: United Kingdom
Website
- Description: Provider of drug delivery devices and manufacturing services for asthma and COPD, offering metered-dose inhalation devices and components (actuators, dose counters), dry powder inhalers including PowdAir Plus, comprehensive drug delivery device development from design to manufacturing, high-precision injection moulding, automated multi-component assembly, and deep drawing of metal components such as MDI cans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full H&T Presspart company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cure Pharmaceutical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cure Pharmaceutical
2.2 - Growth funds investing in similar companies to Cure Pharmaceutical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cure Pharmaceutical
4.2 - Public trading comparable groups for Cure Pharmaceutical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →